DuPont announced the immediate appointment of D.G. Macpherson to its Board of Directors. Macpherson, currently Chairman and CEO of W.W. Grainger, Inc., brings over a decade of executive leadership in operations, supply chain optimization and business transformation. His track record at Grainger—where he has overseen global strategy, single-channel online growth and international expansions—aligns with DuPont’s focus on driving efficiency and scaling innovation across its four core markets: healthcare, water, construction and transportation.

Investors can expect Macpherson’s deep expertise in continuous improvement methodologies, honed during his tenure as COO and Group President at Grainger, to accelerate DuPont’s operational excellence initiatives. His experience implementing availability improvement and pricing strategies at Grainger addresses key margin drivers for DuPont’s advanced materials and specialty products. This appointment underlines DuPont’s commitment to leverage best-in-class supply chain practices as it pursues higher profitability and free cash flow targets over the next three years.

Macpherson’s addition expands DuPont’s board to 12 members, enhancing its mix of industrial distribution, consulting and manufacturing expertise. His prior service on the International Paper Company board and current roles with the Griffin Museum of Science and Industry and the Civic Committee of the Commercial Club of Chicago strengthen DuPont’s stakeholder network across North America and Europe. Increased board diversity of experience may bolster oversight of risk management, particularly in raw-material sourcing, geopolitics and emerging regulatory requirements in sustainable chemicals.

The appointment signals DuPont’s strategy to bridge operational rigor with innovation-led growth. Macpherson’s customer-first mindset and continuous-improvement focus could drive cost reductions and faster commercialization cycles for DuPont’s high-margin product lines. For investors, this governance enhancement suggests a disciplined approach to capital allocation—balancing R&D investments in next-generation materials with targeted efficiency gains that support the company’s medium-term earnings and return-on-capital objectives.